Pyridoxine-doxylamine drug safety data lacking

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research out of St. Michael's Hospital

The pyridoxine-doxylamine is so popular that it has been prescribed in 33 million women worldwide. It's used in half of Canadian pregnancies that result in live births. The Society of Obstetricians and Gynecologists of Canada lists it as the standard of care for women with nausea and vomiting "since it has the greatest evidence to support its efficacy and safety."

"When prescribing the drug to one of my patients she had a lot questions," said Dr. Nav Persaud, a family and community medicine physician at St. Michael's Hospital. "I found myself making strong statements about its safety and realized that I should know more."

He went back and looked at all of the data that led to pyridoxine-doxylamine's top safety ranking. Dr. Persaud found that the number of patients that were part of the original studies wasn't more than 200,000, as previously stated, but was closer to 130,000. The drug's safety data – numbers that are still cited and used by clinicians today – said that the use of the drug decreased the risk of such as limb malformation or .

"The numbers didn't add up," said Dr. Persaud, who is also a scientist in the hospital's Li Ka Shing Knowledge Institute . "Despite claims that it reduced the risks of birth defects, data was much closer to natural average of birth defects – between three and five per cent of all pregnancies."

The commentary, published today in Journal of Obstetrics and Gynaecology Canada, examines the primary studies that formed the basis of the Canadian guideline recommendations for pyridoxine-doxylamine.

After reviewing the reports and studies, Dr. Persaud said he found the evidence lacking.

"The guidelines should change," said Dr. Persaud.

Anti-nausea alternatives exist and are already used more frequently in other parts of the world. Pyridoxine, without doxylamine, has stronger safety data supporting it, but is prescribed less often.

Dr. Persaud said he was concerned that some patients may still prefer taking pyridoxine-doxylamine because they used it in previous pregnancies or because they've read about its and know the drug is considered standard of care.

"Vitamin B6 is similarly effective at treating nausea and vomiting in pregnancy," said Dr. Persaud. "I've changed my practice and now recommend alternatives to pyridoxine-doxylamine that have been demonstrated to be safe."

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

14 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments